At the diagnosis of second recurrence of ovarian cancer, significantly higher HE4 levels were found among patients with left neoplastic residues > 10 mm, when compared to the group without any tumor residues after the primary surgery (p = 0.045). This evidence concerns the gene WFDC2 and ovarian cancer.